Unknown

Dataset Information

0

Rapid and accurate agglutination-based testing for SARS-CoV-2 antibodies.


ABSTRACT: We have developed a rapid, accurate, and cost-effective serologic test for SARS-CoV-2 virus, which caused the COVID-19 pandemic, on the basis of antibody-dependent agglutination of antigen-coated latex particles. When validated using plasma samples that are positive or negative for SARS-CoV-2, the agglutination assay detected antibodies against the receptor-binding domain of the spike (S-RBD) or the nucleocapsid protein of SARS-CoV-2 with 100% specificity and ∼98% sensitivity. Furthermore, we found that the strength of the S-RBD antibody response measured by the agglutination assay correlated with the efficiency of the plasma in blocking RBD binding to the angiotensin-converting enzyme 2 in a surrogate neutralization assay, suggesting that the agglutination assay might be used to identify individuals with virus-neutralizing antibodies. Intriguingly, we found that >92% of patients had detectable antibodies on the day of a positive viral RNA test, suggesting that the agglutination antibody test might complement RNA testing for the diagnosis of SARS-CoV-2 infection.

SUBMITTER: Esmail S 

PROVIDER: S-EPMC8114573 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC7959259 | biostudies-literature
| S-BSST379 | biostudies-other
| S-EPMC8558107 | biostudies-literature
| S-EPMC7370531 | biostudies-literature
| S-SCDT-10_1038-S44318-024-00061-0 | biostudies-other
| S-EPMC8635686 | biostudies-literature
| S-EPMC7953531 | biostudies-literature
| S-EPMC8552600 | biostudies-literature
| S-EPMC8182346 | biostudies-literature
| S-EPMC8820412 | biostudies-literature